- Home
- MHUA vs BFRI Comparison
MHUA vs BFRI Comparison
Compare MHUA & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- BFRI
- Stock Information
- Founded
- MHUA 1990
- BFRI 1997
- Country
- MHUA China
- BFRI United States
- Employees
- MHUA N/A
- BFRI N/A
- Industry
- MHUA Medical Specialities
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- MHUA Health Care
- BFRI Health Care
- Exchange
- MHUA Nasdaq
- BFRI Nasdaq
- Market Cap
- MHUA 13.3M
- BFRI 11.4M
- IPO Year
- MHUA 2022
- BFRI 2021
- Fundamental
- Price
- MHUA $0.38
- BFRI $1.01
- Analyst Decision
- MHUA
- BFRI Strong Buy
- Analyst Count
- MHUA 0
- BFRI 1
- Target Price
- MHUA N/A
- BFRI $2.75
- AVG Volume (30 Days)
- MHUA 135.7K
- BFRI 100.4K
- Earning Date
- MHUA 09-19-2025
- BFRI 11-12-2025
- Dividend Yield
- MHUA N/A
- BFRI N/A
- EPS Growth
- MHUA N/A
- BFRI N/A
- EPS
- MHUA 0.29
- BFRI N/A
- Revenue
- MHUA $89,547,563.00
- BFRI $39,188,000.00
- Revenue This Year
- MHUA N/A
- BFRI $9.70
- Revenue Next Year
- MHUA N/A
- BFRI $12.58
- P/E Ratio
- MHUA $1.28
- BFRI N/A
- Revenue Growth
- MHUA N/A
- BFRI 11.20
- 52 Week Low
- MHUA $0.25
- BFRI $0.54
- 52 Week High
- MHUA $1.17
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- MHUA N/A
- BFRI 66.56
- Support Level
- MHUA N/A
- BFRI $1.00
- Resistance Level
- MHUA N/A
- BFRI $1.09
- Average True Range (ATR)
- MHUA 0.00
- BFRI 0.07
- MACD
- MHUA 0.00
- BFRI 0.01
- Stochastic Oscillator
- MHUA 0.00
- BFRI 91.50
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.